REMINDER: #OHSEN Field Opposes Efforts To Lower Prescription Drug Costs
February 1, 2024
The Field Also Supports Eliminating The Affordable Care Act – Which Would Jeopardize Care For Millions of Ohioans
Columbus, OH – As Medicare drug price negotiations begin today, here is a reminder that Bernie Moreno, Frank LaRose, and Matt Dolan oppose efforts to lower prescription drug costs. The field also supports eliminating the Affordable Care Act, which would jeopardize care for 857,000 Ohioans and risk denying care to nearly 2 million Ohioans with a preexisting condition.
“From wanting to overturn the Affordable Care Act to opposing efforts to lower drug costs, Bernie Moreno, Frank LaRose, and Matt Dolan are looking out for Big Pharma – not Ohioans,” said ODP spokesperson Katie Smith. “Ohioans can’t trust Moreno, LaRose, or Dolan to fight for them.”
What repealing the Inflation Reduction Act and halting Medicare negotiations would mean for Ohioans:
- Without the Inflation Reduction Act, Medicare would not be empowered to negotiate directly with pharmaceutical companies to lower drug prices for Ohioans.
- Without the Inflation Reduction Act, which capped the cost of insulin at $35 a month, Ohioans would be forced to pay hundreds of dollars for life-saving medication.
- Without the Inflation Reduction Act, Ohioans on Medicare would be forced to pay higher prices on 43 common prescriptions that drug companies often overcharge for.